Additionally, the corresponding DUB responsible for removing such ubiquitination on LKB1 and suppressing LKB1 kinase activity can be of great interest as an oncogenic factor and potential therapeutic target for NSCLC. This evidence concerns the gene ZUP1 and non-small cell lung carcinoma.